Nxera Pharma’s oral receptor agonist advances in schizophrenia trials with successful preclinical milestone April 16, 2024 AutoBot News 0 Nxera Pharma Co., Ltd is celebrating a significant milestone in its collaboration with Neurocrine Biosciences Inc.